Investor profile
Parkwalk Advisors
VC
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Parkwalk Advisors is the UK's most active investor in university spinouts, backing world-changing deeptech companies emerging from the UK's leading academic institutions. The firm bridges the funding gap between early academic discovery and later-stage venture capital, investing from Seed to Series C across three core verticals — DeepTech (AI, quantum computing, hardware, materials), HealthTech (life sciences, digital health, MedTech), and CleanTech (agtech, future mobility). As Parkwalk states, it backs 'the boldest, most visionary university spinouts, providing the funding, expertise, and networks they need to thrive.' Operating as a leading EIS fund manager and as part of IP Group plc, Parkwalk leverages deep partnerships with the technology-transfer offices of Oxford, Cambridge, Imperial College, and Bristol to access exceptional founders and world-class IP long before they reach the wider market.
Notable quotes
“Spinouts are the future of this economy. It is where the UK has real comparative strength – capitalising on our world-leading research base. The companies raising record sums of investment in 2024 are tackling the biggest challenges of our time – from climate change to AI and healthcare.”
“2024 marked an exceptional rebound, with investment into spinouts rising to £3.35 billion, more than 40% higher than the previous year. Landmark raises and a robust pipeline of early-stage deals drove this growth. Despite a more challenging start to 2025, the sector has demonstrated ongoing resilience.”
“Many of the fledgling firms I worked with then are now high-value companies, innovating to overcome challenges in health, climate, and the boundaries of technology. This year's Equity Report shows the resilience and potential of this ecosystem.”
Team
John Pearson
Chief Investment Officer
Anne Dobrée
Investment Director
Martin Glen
Investment Director
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Quantum Motion | Series C | $160m | 2026-05-07 |
| Semarion | Series A | — | 2026-03 |
| Brainomix | Series C Extension | — | 2026-02 |
| Riverlane | Series C | $75m | 2025-12 |
| Phasecraft | Series B | — | 2025-09 |
| Paragraf | Series B | — | 2022 |
| Oxford Endovascular | Series A | $10m | 2024-05-20 |
| Cambridge GaN Devices | Series A | — | 2022 |
| Psyomics | Seed | — | 2021 |
| adsilico | Seed | $4m | 2024-02-29 |
Frequent co-investors
Fit check
Is Parkwalk Advisors a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit